1. Feasibility and cost of a telemedicine-based short-term plan for initial access in general dermatology in Andalusia, SpainCapsule Summary
- Author
-
Ruben Barros-Tornay, MD, Lara Ferrándiz, MD, PhD, Francisco J. Martín-Gutiérrez, MD, Almudena Fernández-Orland, MD, Amalia Serrano-Gotarredona, MD, José M. de la Torre, MD, María D. Conejo-Mir, MD, Teresa Ojeda-Vila, MD, PhD, Juan Márquez-Enríquez, MD, Carlos Hernández, MD, María J. Ocaña, MD, Juan M. Herrerías-Esteban, MD, and David Moreno-Ramírez, MD, PhD
- Subjects
accessibility ,dermatology care ,health care services ,technology ,teledermatology ,telemedicine ,Dermatology ,RL1-803 - Abstract
Background: In developed countries, health care delivery in dermatology is hampered by the low availability of dermatologists. Objective: To analyze the feasibility of a teledermatology-based action plan to provide initial dermatologic care in areas with low availability of dermatologists. Methods: A cross-sectional study describing the feasibility and cost of a 12-month action plan based on a store-and-forward teledermatology (TD) connecting primary care centers and a TD center. Teleconsultations from patients complaining of any cutaneous condition were included. The primary outcome measure was the percentage of patients not referred to the local dermatologist. Results: Among the total of 15,523 teleconsultations attended in the TD-based action plan, 3360 (21.65%) required a face-to-face visit with a local dermatologist. In 32.32% (n = 5017) of the cases, a therapeutic and follow-up plan report was issued. The most common conditions managed were melanocytic nevi (15.63%, n = 2426), followed by seborrheic keratosis (14.89%, n = 2312), and actinic keratosis (8.65%, n = 1342). The average response time was 14.52 days (95% CI 14.35-15.23). The additional total investment in this action plan was $142,681.01, with a unit cost of 9.20$/patient. Limitations: Noncontrolled study. Conclusions: Experienced dermatologists working with store-and-forward TD can deliver a fast and effective response in health care areas with access limitations.
- Published
- 2021
- Full Text
- View/download PDF